In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers

Journal of Pathology

Volumn 187, Issue 4, 1999, Pages 446-454

  Bosserhoff, Anja Katrin ^a   Moser, Markus ^a   Hein, Rüdiger ^b   Landthaler, Michael ^a   Buettner, Reinhard ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenocarcinoma; Expression pattern; Melanoma; Melanoma inhibiting activity (MIA)

Indexed keywords

ADVANCED CANCER; ARTICLE; BREAST CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; BREAST NEOPLASMS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MELANOMA; NEOPLASM PROTEINS; NEVUS, PIGMENTED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033014031     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199903)187:4<446::AID-PATH267>3.0.CO;2-Y     Document Type: Article

References (20)

1. Bogdahn U, Apfel R, Hahn M, et al. Autocrine tumor cell growth inhibiting activities from human malignant melanoma. Cancer Res 1989; 49: 5358-5363.
2. Blesch A, Bosserhoff AK, Apfel R, et al. Cloning of a novel malignant melanoma-derived growth regulatory protein, MIA. Cancer Res 1994; 54: 5695-5701.
3. Koehler MR, Bosserhoff AK, von Beust G, et al. Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.4 by fluorescence in situ hybridization (FISH). Genomics 1996; 35: 265-267.
4. Van Groningen JJM, Bloemers HP, Swart GW. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. Cancer Res 1995; 55: 6237-6243.
5. Dietz U, Sandell LJ. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J Biol Chem 1996; 271: 3311-3316.
6. Bosserhoff AK, Kondo S, Moser M, et al. The mouse MIA/CD-RAP gene: structure, chromosomal localization and expression in cartilage and chondrosarcoma. Dev Dyn 1997; 208: 516-525.
7. Bosserhoff AK, Hein R, Bogdahn U, Buettner R. Structure and promoter analysis of the gene encoding the human melanoma-inhibiting-protein, MIA. J Biol Chem 1996; 271: 490-495.
8. Bosserhoff AK, Kaufmann M, Kaluza B, et al. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 1997; 57: 3149-3153.
9. Bosserhoff AK, Lederer M, Kaufmann M, et al. MIA, a novel serum marker for progression of malignant melanoma. Anticancer Res 1997; 57: 3149-3153.
10. Moser M, Pscherer A, Imhof A, et al. Molecular cloning and characterization of a second AP-2 transcription activator gene, AP-2β. Development 1995; 121: 2779-2788.
11. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology 1991; 19: 403-410.
12. Remmele W, Schicketanz KH. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancers. Pathol Res Pract 1993; 189: 862-866.
13. Bocker T, Bittinger A, Wieland W, et al. In vitro and ex vivo expression of nucleolar proteins (B23, p120) in benign and malignant epithelial lesions of the prostate. Mod Pathol 1995; 8: 226-231.
14. Moser M, Pscherer A, Roth C, et al. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2β. Genes Dev 1997; 11: 1938-1948.
15. Wagner SN, Wagner C, Höfler H, Atkinson MJ, Goos M. Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA. Lab Invest 1995; 73: 229-235.
16. Reinhold U, Ludtke-Handjery HC, Schnautz S, Kreysel HW, Abken H. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 1997; 108: 166-169.
17. Reintgen DS, Conrad AJ. Detection of occult melanoma cells in sentinel lymph nodes and blood. Semin Oncol 1997; 24: S11-S15.
18. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867.
19. Lu J, Pei H, Kaeck M, Thompson HJ. Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol Carcinog 1997; 20: 204-215.
20. Rasmussen BB. Human mucinous breast carcinomas and their lymph node metastases. A histological review of 247 cases. Pathol Res Pract 1985; 180: 377-382.